Lantheus Holdings said Thursday that the US Food and Drug Administration has set a March 29 Prescription Drug User Fee Act target action date for the diagnostic imaging kit LNTH-2501. The company...
Lantheus Says FDA Sets Target Action Date for LNTH-2501 Diagnostic Imaging Kit